Income Tax Expense (Benefit) in USD of Nabriva Therapeutics plc from 2014 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Nabriva Therapeutics plc quarterly/annual Income Tax Expense (Benefit) history and change rate from 2014 to Q2 2023.
  • Nabriva Therapeutics plc Income Tax Expense (Benefit) for the quarter ending 30 Jun 2023 was $0.000, a 100% decline year-over-year.
  • Nabriva Therapeutics plc annual Income Tax Expense (Benefit) for 2022 was $1.57M, a 220% increase from 2021.
  • Nabriva Therapeutics plc annual Income Tax Expense (Benefit) for 2021 was $490K, a 253% increase from 2020.
  • Nabriva Therapeutics plc annual Income Tax Expense (Benefit) for 2020 was $139K, a 37.6% increase from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Nabriva Therapeutics plc Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $0 -$385K -100% 01 Apr 2023 30 Jun 2023 10-Q 19 Oct 2023
Q4 2022 $1.57M $309K +$363K 01 Oct 2022 31 Dec 2022 10-K 17 Apr 2023
Q3 2022 $1.21M $520K +$772K 01 Jul 2022 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 $433K $385K -$221K -36.5% 01 Apr 2022 30 Jun 2022 10-Q 19 Oct 2023
Q1 2022 $654K $354K +$164K +86.3% 01 Jan 2022 31 Mar 2022 10-Q 22 May 2023
Q4 2021 $490K -$54K +$6K +10% 01 Oct 2021 31 Dec 2021 10-K 17 Apr 2023
Q3 2021 $484K -$252K -$180K -250% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 $664K $606K +$487K +409% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022
Q1 2021 $177K $190K +$38K +25% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q4 2020 $139K -$60K -$81K -386% 01 Oct 2020 31 Dec 2020 10-K 17 Apr 2023
Q3 2020 $220K -$72K -$43K -148% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 $263K $119K +$164K 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021
Q1 2020 $99K $152K -$2K -1.3% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q4 2019 $101K $21K +$280K 01 Oct 2019 31 Dec 2019 10-K 12 Mar 2020
Q3 2019 -$179K -$29K +$122K +80.8% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020
Q2 2019 -$301K -$45K +$3K +6.25% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020
Q1 2019 -$304K $154K -$352K -69.6% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q4 2018 $48K -$259K -$360K -356% 01 Oct 2018 31 Dec 2018 10-K 12 Mar 2020
Q3 2018 $408K -$151K -$2.02M -108% 01 Jul 2018 30 Sep 2018 10-K 12 Mar 2020
Q2 2018 $2.43M -$48K +$919K +95% 01 Apr 2018 30 Jun 2018 10-K 12 Mar 2020
Q1 2018 $1.51M $506K +$157K +45% 01 Jan 2018 31 Mar 2018 10-K 12 Mar 2020
Q4 2017 $1.36M $101K +$772K 01 Oct 2017 31 Dec 2017 10-K 12 Mar 2019
Q3 2017 $583K $1.87M +$1.84M +6586% 01 Jul 2017 30 Sep 2017 10-K 12 Mar 2019
Q2 2017 -$1.26M -$967K -$955K -7958% 01 Apr 2017 30 Jun 2017 10-K 12 Mar 2019
Q1 2017 -$306K $349K +$366K 01 Jan 2017 31 Mar 2017 10-K 12 Mar 2019
Q4 2016 -$672K -$671K -$466K -227% 01 Oct 2016 31 Dec 2016 10-K 16 Mar 2018
Q3 2016 -$206K $28K +$282K 01 Jul 2016 30 Sep 2016 10-K 16 Mar 2018
Q2 2016 -$488K -$12K -$14K -700% 01 Apr 2016 30 Jun 2016 10-K 16 Mar 2018
Q1 2016 -$474K -$17K -$29K -242% 01 Jan 2016 31 Mar 2016 10-K 16 Mar 2018
Q4 2015 -$445K -$205K 01 Oct 2015 31 Dec 2015 10-K 24 Mar 2017
Q3 2015 -$254K 01 Jul 2015 30 Sep 2015 10-K 24 Mar 2017
Q2 2015 $2K 01 Apr 2015 30 Jun 2015 10-K 24 Mar 2017
Q1 2015 $12K 01 Jan 2015 31 Mar 2015 10-K 24 Mar 2017

Nabriva Therapeutics plc Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $1.57M +$1.08M +220% 01 Jan 2022 31 Dec 2022 10-K 17 Apr 2023
2021 $490K +$351K +253% 01 Jan 2021 31 Dec 2021 10-K 17 Apr 2023
2020 $139K +$38K +37.6% 01 Jan 2020 31 Dec 2020 10-K 17 Apr 2023
2019 $101K +$52K +106% 01 Jan 2019 31 Dec 2019 10-K 29 Mar 2022
2018 $49K -$1.31M -96.4% 01 Jan 2018 31 Dec 2018 10-K 11 Mar 2021
2017 $1.36M +$2.03M 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2020
2016 -$672K -$227K -51% 01 Jan 2016 31 Dec 2016 10-K 12 Mar 2019
2015 -$445K -$539K -573% 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2018
2014 $94K 01 Jan 2014 31 Dec 2014 10-K 24 Mar 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.